PHLB-news is out
biz.yahoo.com
PHLB Announces It Will Begin Shipments of 'The Potency Solution', a Natural Herbal Alternative to Viagra, Later This Month
CORPUS CHRISTI, Texas, Nov 3, 1999 (BW HealthWire) -- Pharmaceutical Laboratories, Inc. (OTC-BB:PHLB), a leader in nutraceuticals with advanced liquid nutritional products, today announced that its most recent product, "The Potency Solution", will be ready for shipment later this month.
The Potency Solution is a part of the nutraceutical line of products, and features a combination of natural ingredients in a special liquid formula that are known to be effective in treating sexual dysfunction. The Potency Solution comes in a 16-oz. bottle that contains thirty-two doses and retails for $29.95.
Pharmaceutical Laboratories President and Chief executive Officer of PHLB Jerry McClure states, "Studies indicate that each of the nutrients found in our solution is a potency-enhancer by itself, but together they form a very powerful combination." McClure went on to say, "Since the introduction of Viagra(r), many new herbal and vitamin combinations, in pill form, have hit the market claiming to be 'just as effective,' but we believe that our Potency Solution will prove to be the best because liquids are simply more effective and faster acting.
Pharmaceutical Laboratories, Inc. specializes in the development, manufacturing, and marketing of liquid nutraceutical products in the U.S. and abroad. The Company's products are manufactured in their own production facilities under strict quality standards, with each batch tested for potency, purity, and stability to guarantee the accuracy of its label claims.
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, the Company's dependence on third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
Copyright (C) 1999 Business Wire. All rights reserved.
CONTACT: OTC Financial Network
Mario "Ike" Iacoviello, 800-863-1431 / 760-931-9211
ike@otcfn.com
www.otcfn.com/phlb
or
Pharmaceutical Laboratories
George Baucom, 800-856-7040
george@phlb.com
liquidsolutionsonline.com
WEB PAGE: businesswire.com |
